Acrivon Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Watertown, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Acrivon Therapeutics, Inc. has filed 331 SEC EDGAR filings since 12 Feb 2021

SEC filing history

Showing 176-200 of 331 matching filings.

Per page
25
Current page
8
4

4 filing

Filing date
24 Jun 2024
Reporting date
20 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
24 Jun 2024
Reporting date
20 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
21 May 2024
Reporting date
17 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 May 2024
Reporting date
14 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 May 2024
Reporting date
14 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 May 2024
Reporting date
14 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 May 2024
Reporting date
14 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 May 2024
Reporting date
14 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 May 2024
Reporting date
14 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 May 2024
Reporting date
14 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
16 May 2024
Reporting date
13 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-278761

EFFECT filing

Filing date
29 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-41551

ARS

Filing date
26 Apr 2024
Reporting date
31 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-41551

DEFA14A

Filing date
26 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-41551

DEF 14A

Filing date
26 Apr 2024
Reporting date
20 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
24 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
19 Apr 2024
Reporting date
17 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-278761

UPLOAD filing

Filing date
19 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-278761

S-3

Filing date
17 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
15 Apr 2024
Reporting date
11 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
15 Apr 2024
Reporting date
11 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .